{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:05:37Z","timestamp":1794258337425,"version":"4.9.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Nanotechnol."],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1038\/s41565-024-01687-1","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T06:02:20Z","timestamp":1718776940000},"page":"1386-1398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":188,"title":["Resolvin D1 delivery to lesional macrophages using antioxidative black phosphorus nanosheets for atherosclerosis treatment"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2108-7929","authenticated-orcid":false,"given":"Zhongshan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2909-3023","authenticated-orcid":false,"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2448-2254","authenticated-orcid":false,"given":"Kuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9773-7495","authenticated-orcid":false,"given":"Xi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6882-7862","authenticated-orcid":false,"given":"Yongjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-322X","authenticated-orcid":false,"given":"Lin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiding","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8649-3453","authenticated-orcid":false,"given":"Shuping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengran","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7114-1095","authenticated-orcid":false,"given":"Xingcai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qimanguli","family":"Saiding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4719-9921","authenticated-orcid":false,"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3001-9605","authenticated-orcid":false,"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2853-2696","authenticated-orcid":false,"given":"Xiangrong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4277-3728","authenticated-orcid":false,"given":"Wei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"key":"1687_CR1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"KJ Moore","year":"2011","unstructured":"Moore, K. J. & Tabas, I. Macrophages in the pathogenesis of atherosclerosis. Cell 145, 341\u2013355 (2011).","journal-title":"Cell"},{"key":"1687_CR2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri2675","volume":"10","author":"I Tabas","year":"2010","unstructured":"Tabas, I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10, 36\u201346 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"1687_CR3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby, P. The changing landscape of atherosclerosis. Nature 592, 524\u2013533 (2021).","journal-title":"Nature"},{"key":"1687_CR4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41569-021-00629-x","volume":"19","author":"W Chen","year":"2022","unstructured":"Chen, W. et al. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis. Nat. Rev. Cardiol. 19, 228\u2013249 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"1687_CR5","first-page":"389","volume":"16","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck, M., Yurdagul, A., Tabas, I., \u00d6\u00f6rni, K. & Kovanen, P. T. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat. Rev. Cardiol. 16, 389\u2013406 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"1687_CR6","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1172\/JCI97950","volume":"128","author":"C Kasikara","year":"2018","unstructured":"Kasikara, C., Doran, A. C., Cai, B. & Tabas, I. The role of non-resolving inflammation in atherosclerosis. J. Clin. Invest. 128, 2713\u20132723 (2018).","journal-title":"J. Clin. Invest."},{"key":"1687_CR7","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1687_CR8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","volume":"380","author":"PM Ridker","year":"2019","unstructured":"Ridker, P. M. et al. Low-dose methotrexate for the prevention of atherosclerotic events. N. Engl. J. Med. 380, 752\u2013762 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1687_CR9","doi-asserted-by":"crossref","first-page":"eaay1063","DOI":"10.1126\/scitranslmed.aay1063","volume":"12","author":"W Tao","year":"2020","unstructured":"Tao, W. et al. siRNA nanoparticles targeting CaMKII\u03b3 in lesional macrophages improve atherosclerotic plaque stability in mice. Sci. Transl. Med. 12, eaay1063 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1687_CR10","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1021\/acsnano.6b01114","volume":"10","author":"N Kamaly","year":"2016","unstructured":"Kamaly, N. et al. Targeted interleukin-10 nanotherapeutics developed with a microfluidic chip enhance resolution of inflammation in advanced atherosclerosis. ACS Nano 10, 5280\u20135292 (2016).","journal-title":"ACS Nano"},{"key":"1687_CR11","first-page":"275ra20","volume":"7","author":"G Fredman","year":"2015","unstructured":"Fredman, G. et al. Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci. Transl. Med. 7, 275ra20 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1687_CR12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","volume":"12","author":"GK Hansson","year":"2011","unstructured":"Hansson, G. K. & Hermansson, A. The immune system in atherosclerosis. Nat. Immunol. 12, 204\u2013212 (2011).","journal-title":"Nat. Immunol."},{"key":"1687_CR13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/CIRCRESAHA.114.302153","volume":"114","author":"Y Wang","year":"2014","unstructured":"Wang, Y., Wang, G. Z., Rabinovitch, P. S. & Tabas, I. Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-\u03baB-mediated inflammation in macrophages. Circ. Res. 114, 421\u2013433 (2014).","journal-title":"Circ. Res."},{"key":"1687_CR14","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","volume":"114","author":"JF Bentzon","year":"2014","unstructured":"Bentzon, J. F., Otsuka, F., Virmani, R. & Falk, E. Mechanisms of plaque formation and rupture. Circ. Res. 114, 1852\u20131866 (2014).","journal-title":"Circ. Res."},{"key":"1687_CR15","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","volume":"38","author":"P Libby","year":"2013","unstructured":"Libby, P., Lichtman, A. H. & Hansson, G. K. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 38, 1092\u20131104 (2013).","journal-title":"Immunity"},{"key":"1687_CR16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P Libby","year":"2011","unstructured":"Libby, P., Ridker, P. M. & Hansson, G. K. Progress and challenges in translating the biology of atherosclerosis. Nature 473, 317\u2013325 (2011).","journal-title":"Nature"},{"key":"1687_CR17","doi-asserted-by":"crossref","first-page":"1904607","DOI":"10.1002\/adma.201904607","volume":"31","author":"J Guo","year":"2019","unstructured":"Guo, J. et al. Cyclodextrin-derived intrinsically bioactive nanoparticles for treatment of acute and chronic inflammatory diseases. Adv. Mater. 31, 1904607 (2019).","journal-title":"Adv. Mater."},{"key":"1687_CR18","doi-asserted-by":"crossref","first-page":"28667","DOI":"10.1073\/pnas.2016268117","volume":"117","author":"J Ouyang","year":"2020","unstructured":"Ouyang, J. et al. In situ sprayed NIR-responsive, analgesic black phosphorus-based gel for diabetic ulcer treatment. Proc. Natl Acad. Sci. USA 117, 28667\u201328677 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1687_CR19","volume":"11","author":"K Hu","year":"2020","unstructured":"Hu, K. et al. Marriage of black phosphorus and Cu2+ as effective photothermal agents for PET-guided combination cancer therapy. Nat. Commun. 11, 2778 (2020).","journal-title":"Nat. Commun."},{"key":"1687_CR20","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1039\/D0CS01175D","volume":"50","author":"C Liu","year":"2021","unstructured":"Liu, C. et al. Pnictogens in medicinal chemistry: evolution from erstwhile drugs to emerging layered photonic nanomedicine. Chem. Soc. Rev. 50, 2260\u20132279 (2021).","journal-title":"Chem. Soc. Rev."},{"key":"1687_CR21","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1039\/C8CS00823J","volume":"48","author":"W Tao","year":"2019","unstructured":"Tao, W. et al. Emerging two-dimensional monoelemental materials (Xenes) for biomedical applications. Chem. Soc. Rev. 48, 2891\u20132912 (2019).","journal-title":"Chem. Soc. Rev."},{"key":"1687_CR22","doi-asserted-by":"crossref","first-page":"1603276","DOI":"10.1002\/adma.201603276","volume":"29","author":"W Tao","year":"2017","unstructured":"Tao, W. et al. Black phosphorus nanosheets as a robust delivery platform for cancer theranostics. Adv. Mater. 29, 1603276 (2017).","journal-title":"Adv. Mater."},{"key":"1687_CR23","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1021\/acs.nanolett.9b05218","volume":"20","author":"J Hou","year":"2020","unstructured":"Hou, J. et al. Treating acute kidney injury with antioxidative black phosphorus nanosheets. Nano Lett. 20, 1447\u20131454 (2020).","journal-title":"Nano Lett."},{"key":"1687_CR24","volume":"7","author":"G Fredman","year":"2016","unstructured":"Fredman, G. et al. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. Nat. Commun. 7, 12859 (2016).","journal-title":"Nat. Commun."},{"key":"1687_CR25","doi-asserted-by":"crossref","first-page":"14530","DOI":"10.1073\/pnas.1410851111","volume":"111","author":"G Fredman","year":"2014","unstructured":"Fredman, G. et al. Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway. Proc. Natl Acad. Sci. USA 111, 14530\u201314535 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1687_CR26","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41596-021-00665-4","volume":"17","author":"X Huang","year":"2021","unstructured":"Huang, X. et al. Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in atherosclerotic lesional macrophages. Nat. Protoc. 17, 748\u2013780 (2021).","journal-title":"Nat. Protoc."},{"key":"1687_CR27","volume":"11","author":"C Gao","year":"2020","unstructured":"Gao, C. et al. Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines. Nat. Commun. 11, 2622 (2020).","journal-title":"Nat. Commun."},{"key":"1687_CR28","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.jacc.2018.08.2188","volume":"72","author":"J Cheng","year":"2018","unstructured":"Cheng, J. et al. A targeting nanotherapy for abdominal aortic aneurysms. J. Am. Coll. Cardiol. 72, 2591\u20132605 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1687_CR29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biomaterials.2017.07.035","volume":"143","author":"Y Dou","year":"2017","unstructured":"Dou, Y. et al. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis. Biomaterials 143, 93\u2013108 (2017).","journal-title":"Biomaterials"},{"key":"1687_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.08.011","volume":"312","author":"M Lee-Rueckert","year":"2020","unstructured":"Lee-Rueckert, M. et al. Acidic extracellular pH promotes accumulation of free cholesterol in human monocyte-derived macrophages via inhibition of ACAT1 activity. Atherosclerosis 312, 1\u20137 (2020).","journal-title":"Atherosclerosis"},{"key":"1687_CR31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0021-9150(02)00018-7","volume":"164","author":"M Naghavi","year":"2002","unstructured":"Naghavi, M. et al. pH heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque. Atherosclerosis 164, 27\u201335 (2002).","journal-title":"Atherosclerosis"},{"key":"1687_CR32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.apsb.2022.04.002","volume":"13","author":"X Liang","year":"2023","unstructured":"Liang, X. et al. Highly sensitive H2O2-scavenging nano-bionic system for precise treatment of atherosclerosis. Acta Pharm. Sin. B 13, 372\u2013389 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"1687_CR33","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1073\/pnas.93.7.2774","volume":"93","author":"J Hambleton","year":"1996","unstructured":"Hambleton, J., Weinstein, S. L., Lem, L. & Defranco, A. L. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl Acad. Sci. USA 93, 2774\u20132778 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1687_CR34","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1002\/anie.202016330","volume":"60","author":"W Chen","year":"2021","unstructured":"Chen, W. et al. Stanene-based nanosheets for \u03b2-elemene delivery and ultrasound-mediated combination cancer therapy. Angew. Chem. Int. Ed. 60, 7155\u20137164 (2021).","journal-title":"Angew. Chem. Int. Ed."},{"key":"1687_CR35","doi-asserted-by":"crossref","first-page":"1901211","DOI":"10.1002\/advs.201901211","volume":"6","author":"X Ji","year":"2019","unstructured":"Ji, X. et al. Synthesis of ultrathin biotite nanosheets as an intelligent theranostic platform for combination cancer therapy. Adv. Sci. 6, 1901211 (2019).","journal-title":"Adv. Sci."},{"key":"1687_CR36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41418-019-0370-1","volume":"27","author":"BD Gerlach","year":"2020","unstructured":"Gerlach, B. D. et al. Resolvin D1 promotes the targeting and clearance of necroptotic cells. Cell Death Differ. 27, 525\u2013539 (2020).","journal-title":"Cell Death Differ."},{"key":"1687_CR37","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/ATVBAHA.120.315758","volume":"41","author":"Z Hosseini","year":"2021","unstructured":"Hosseini, Z. et al. Resolvin D1 enhances necroptotic cell clearance through promoting macrophage fatty acid oxidation and oxidative phosphorylation. Arterioscler. Thromb. Vasc. Biol. 41, 1062\u20131075 (2021).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1687_CR38","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1073\/pnas.1303377110","volume":"110","author":"N Kamaly","year":"2013","unstructured":"Kamaly, N. et al. Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles. Proc. Natl Acad. Sci. USA 110, 6506\u20136511 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1687_CR39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"EK Jo","year":"2016","unstructured":"Jo, E. K., Kim, J. K., Shin, D. M. & Sasakawa, C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell. Mol. Immunol. 13, 148\u2013159 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"1687_CR40","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2016.03.046","volume":"165","author":"VAK Rathinam","year":"2016","unstructured":"Rathinam, V. A. K. & Fitzgerald, K. A. Inflammasome complexes: emerging mechanisms and effector functions. Cell 165, 792\u2013800 (2016).","journal-title":"Cell"},{"key":"1687_CR41","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1002\/anie.201913700","volume":"132","author":"G Wu","year":"2020","unstructured":"Wu, G. et al. Molecularly engineered macrophage\u2010derived exosomes with inflammation tropism and intrinsic heme biosynthesis for atherosclerosis treatment. Angew. Chem. Int. Ed. 132, 4068\u20134074 (2020).","journal-title":"Angew. Chem. Int. Ed."},{"key":"1687_CR42","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd3578","volume":"10","author":"ME Lobatto","year":"2011","unstructured":"Lobatto, M. E., Fuster, V., Fayad, Z. A. & Mulder, W. J. M. Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat. Rev. Drug Discov. 10, 835\u2013852 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1687_CR43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41569-018-0073-1","volume":"16","author":"R Duivenvoorden","year":"2019","unstructured":"Duivenvoorden, R. et al. Nanoimmunotherapy to treat ischaemic heart disease. Nat. Rev. Cardiol. 16, 21\u201332 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"1687_CR44","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/ATVBAHA.118.311569","volume":"39","author":"AM Flores","year":"2019","unstructured":"Flores, A. M. et al. Nanoparticle therapy for vascular diseases. Arterioscler. Thromb. Vasc. Biol. 39, 635\u2013646 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1687_CR45","first-page":"239sr1","volume":"6","author":"WJM Mulder","year":"2014","unstructured":"Mulder, W. J. M., Jaffer, F. A., Fayad, Z. A. & Nahrendorf, M. Imaging and nanomedicine in inflammatory atherosclerosis. Sci. Transl. Med. 6, 239sr1 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1687_CR46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41551-018-0221-2","volume":"2","author":"M Lameijer","year":"2018","unstructured":"Lameijer, M. et al. Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates. Nat. Biomed. Eng. 2, 279\u2013292 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"1687_CR47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41565-019-0619-3","volume":"15","author":"AM Flores","year":"2020","unstructured":"Flores, A. M. et al. Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis. Nat. Nanotechnol. 15, 154\u2013161 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"1687_CR48","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.ATV.0000067937.93716.DB","volume":"23","author":"GN Fredrikson","year":"2003","unstructured":"Fredrikson, G. N. et al. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler. Thromb. Vasc. Biol. 23, 879\u2013884 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1687_CR49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI25074","volume":"116","author":"PJ Gough","year":"2006","unstructured":"Gough, P. J., Gomez, I. G., Wille, P. T. & Raines, E. W. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J. Clin. Invest. 116, 59\u201369 (2006).","journal-title":"J. Clin. Invest."},{"key":"1687_CR50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2004.08.030","volume":"178","author":"YZ Kong","year":"2005","unstructured":"Kong, Y. Z. et al. Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques. Atherosclerosis 178, 207\u2013215 (2005).","journal-title":"Atherosclerosis"},{"key":"1687_CR51","doi-asserted-by":"crossref","first-page":"e1400223","DOI":"10.1126\/sciadv.1400223","volume":"1","author":"J Tang","year":"2015","unstructured":"Tang, J. et al. Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation. Sci. Adv. 1, e1400223 (2015).","journal-title":"Sci. Adv."},{"key":"1687_CR52","volume":"5","author":"R Duivenvoorden","year":"2014","unstructured":"Duivenvoorden, R. et al. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. Nat. Commun. 5, 3065 (2014).","journal-title":"Nat. Commun."},{"key":"1687_CR53","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/ATVBAHA.115.307057","volume":"36","author":"S Nakashiro","year":"2016","unstructured":"Nakashiro, S. et al. Pioglitazone-incorporated nanoparticles prevent plaque destabilization and rupture by regulating monocyte\/macrophage differentiation in ApoE\u2212\/\u2212 mice. Arterioscler. Thromb. Vasc. Biol. 36, 491\u2013500 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1687_CR54","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.113.002870","volume":"129","author":"S Katsuki","year":"2014","unstructured":"Katsuki, S. et al. Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization\/rupture in mice by regulating the recruitment of inflammatory monocytes. Circulation 129, 896\u2013906 (2014).","journal-title":"Circulation"},{"key":"1687_CR55","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1161\/RES.0000000000000110","volume":"119","author":"KK Griendling","year":"2016","unstructured":"Griendling, K. K. et al. Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system. Circ. Res. 119, e39\u2013e75 (2016).","journal-title":"Circ. Res."},{"key":"1687_CR56","volume":"13","author":"SH Jung","year":"2022","unstructured":"Jung, S. H. et al. Spatiotemporal dynamics of macrophage heterogeneity and a potential function of Trem2hi macrophages in infarcted hearts. Nat. Commun. 13, 4580 (2022).","journal-title":"Nat. Commun."},{"key":"1687_CR57","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.117.312513","volume":"122","author":"H Winkels","year":"2018","unstructured":"Winkels, H. et al. Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry. Circ. Res. 122, 1675\u20131688 (2018).","journal-title":"Circ. Res."},{"key":"1687_CR58","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/CIRCRESAHA.118.312804","volume":"123","author":"K Kim","year":"2018","unstructured":"Kim, K. et al. Transcriptome analysis reveals non-foamy rather than foamy plaque macrophages are pro-inflammatory in atherosclerotic murine models. Circ. Res. 123, 1127\u20131142 (2018).","journal-title":"Circ. Res."},{"key":"1687_CR59","volume":"11","author":"T Liu","year":"2020","unstructured":"Liu, T. et al. Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases. Nat. Commun. 11, 2788 (2020).","journal-title":"Nat. Commun."},{"key":"1687_CR60","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/cvr\/cvab193","volume":"118","author":"SH Ni","year":"2022","unstructured":"Ni, S. H. et al. Single-cell transcriptomic analyses of cardiac immune cells reveal that Rel-driven CD72-positive macrophages induce cardiomyocyte injury. Cardiovasc. Res. 118, 1303\u20131320 (2022).","journal-title":"Cardiovasc. Res."},{"key":"1687_CR61","doi-asserted-by":"crossref","unstructured":"Jin, Z.-H. et al. Radiotheranostic agent 64Cu-cyclam-RAFT-c(-RGDfK-)4 for management of peritoneal metastasis in ovarian cancer. Clin. Cancer Res. 26, 6230\u20136241 (2020).","DOI":"10.1158\/1078-0432.CCR-20-1205"},{"key":"1687_CR62","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41587-022-01528-3","volume":"41","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y. et al. Wireless, closed-loop, smart bandage with integrated sensors and stimulators for advanced wound care and accelerated healing. Nat. Biotechnol. 41, 652\u2013662 (2023).","journal-title":"Nat. Biotechnol."},{"key":"1687_CR63","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.120.046528","volume":"142","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Single-cell transcriptome analysis reveals dynamic cell populations and differential gene expression patterns in control and aneurysmal human aortic tissue. Circulation 142, 1374\u20131388 (2020).","journal-title":"Circulation"},{"key":"1687_CR64","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCRESAHA.117.312509","volume":"122","author":"C Cochain","year":"2018","unstructured":"Cochain, C. et al. Single-cell RNA-seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis. Circ. Res. 122, 1661\u20131674 (2018).","journal-title":"Circ. Res."},{"key":"1687_CR65","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/CIRCRESAHA.119.315175","volume":"125","author":"S McArdle","year":"2019","unstructured":"McArdle, S. et al. Migratory and dancing macrophage subsets in atherosclerotic lesions. Circ. Res. 125, 1038\u20131051 (2019).","journal-title":"Circ. Res."}],"container-title":["Nature Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01687-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01687-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01687-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T09:01:48Z","timestamp":1726650108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01687-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1687"],"URL":"https:\/\/doi.org\/10.1038\/s41565-024-01687-1","relation":{},"ISSN":["1748-3387","1748-3395"],"issn-type":[{"value":"1748-3387","type":"print"},{"value":"1748-3395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"3 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.T. has received consultancy fees, lecture fees, been on the scientific advisory board, or conducted sponsored research at Harvard Medical School\/Brigham and Women\u2019s Hospital for the following entities: Novo Nordisk A\/S, Henlius USA Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}